Search Results - hepatic+malignancy

2 Results Sort By:
Improved Gene Therapy Vectors for the Treatment of Glycogen Storage Disease Type Ia (GSD-1a)
Abstract: GSD-Ia is an inherited disorder of metabolism associated with life-threatening hypoglycemia, hepatic malignancy, and renal failure caused by the deficiency of glucose-6-phosphatase-alpha (G6Pase-alpha or G6PC). Current therapy, which primarily consists of dietary modification, fails to prevent long-term complications in many patients, including...
Published: 4/8/2024   |   Inventor(s): Janice Chou, Barry Byrne
Keywords(s): Chou, GSD-1a, hepatic malignancy, hyperlipidemia, hypoglycemia, National Institute of Child Health and Human Development, NICHD
Category(s): TherapeuticArea > Nephrology, Application > Therapeutics, Collaboration Sought > Licensing, Collaboration Sought > Collaboration, TherapeuticArea > Endocrinology
Gene Therapy Vector for the Treatment of Glycogen Storage Disease Type Ia (GSD-Ia)
Abstract: GSD-Ia is an inherited disorder of metabolism associated with life-threatening hypoglycemia, hepatic malignancy, and renal failure caused by the deficiency of glucose-6-phosphatase-alpha (G6Pase-alpha or G6PC). Current therapy, which primarily consists of dietary modification, fails to prevent long-term complications in many patients, including...
Published: 4/8/2024   |   Inventor(s): Janice Chou
Keywords(s): GSD-Ia, hepatic malignancy, hypoglycemia, renal failure
Category(s): Collaboration Sought > Licensing, TherapeuticArea > Nephrology, Collaboration Sought > Collaboration, Application > Therapeutics
© 2024. All Rights Reserved. Powered by Inteum